Purchase Order 36C25620P0359
Award Date 12/19/19
Potential Completion Date 1/18/20
Potential Value $85K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Pittsburgh, PA 15275, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Veterans Affairs Veterans Health Administration has awarded a firm fixed price purchase order to Pantherx Specialty LLC, doing business as Pantherx Specialty Pharmacy, to provide the drug Ruzurgi (amifampridine) 10 mg tablets with a potential value of $136,387.44. Pantherx Specialty, a subsidiary of Centene Corporation, is a specialty pharmacy focused on rare diseases that has received multiple federal contract awards from the Department of Justice Bureau of Prisons and the...
- The Department of Veterans Affairs Veterans Health Administration awarded a firm fixed price purchase order to Pantherx Specialty LLC, doing business as Pantherx Specialty Pharmacy, to provide the pharmaceutical product Ruzurgi [amifampridine] to Veterans Integrated Service Network 16 facilities. The contract has a potential value of $119,339.01 and a completion date of September 30, 2020. Pantherx Specialty is a subsidiary of Centene Corporation that operates as a specialty pharmacy focused...
- The Department of Veterans Affairs' Veterans Integrated Service Network 22 (VISN 22) awarded a $30,275.65 firm fixed-price purchase order to Pantherx Specialty, LLC on September 16, 2025, for emergency pharmaceutical products. The contract, which carries no set-aside designation, is scheduled for completion by September 30, 2025, and will be performed at the contractor's location in Pittsburgh, Pennsylvania. Pantherx Specialty, LLC, operating as Pantherx Specialty Pharmacy and a subsidiary of...
- Pantherx Specialty, LLC, a Pittsburgh-based specialty pharmacy and subsidiary of Centene Corporation, was awarded a firm fixed-price purchase order valued at $10,896.98 on December 8, 2025, by the Veterans Integrated Service Network 2 (VISN 2), a civilian component of the Department of Veterans Affairs. The contract covers the emergency procurement of TARPEYO (budesonide) 4mg medication, with an ultimate completion date of January 7, 2026. There was no set-aside designation associated with...
- This is a federal contract award from the Veterans Integrated Service Network (VISN) 2, a civilian agency, to Pantherx Specialty, LLC, a for-profit limited liability company based in Pittsburgh, Pennsylvania. The contract is for the emergency procurement of TARPEYO 4mg prescription medication for the New York Harbor region. The contract is a firm fixed-price purchase order with a ceiling value of $10,896.98 and a period of performance ending on August 16, 2025. Pantherx Specialty is the prime...
- This is a firm fixed-price purchase order contract awarded by the Veterans Integrated Service Network (VISN) 2, a civilian agency within the U.S. Department of Veterans Affairs (VA), to Pantherx Specialty, LLC, a for-profit limited liability company and subsidiary of Centene Corporation. The contract is for the delivery of TARPEYO 4mg capsules to the New York Harbor, Margaret Cochran Corbin VA Medical Center. The contract has a ceiling value of $10,896.98 and a period of performance ending on...
- This is a firm fixed price purchase order contract awarded by the Department of Veterans Affairs (VA) to Pantherx Specialty, LLC, a for-profit limited liability company based in Pittsburgh, Pennsylvania. The contract, valued at $10,896.98, is for the supply of TARPEYO 4MG (NDC 81749-0004-01), an emergency pharmaceutical product, to the VA's Veterans Integrated Service Network (VISN) 2. The contract has an ultimate completion date of July 30, 2025. Pantherx Specialty is the prime contractor,...
- The U.S. Department of Veterans Affairs (VA) awarded a $10,896.98 firm fixed-price purchase order contract to Pantherx Specialty, LLC, a for-profit limited liability company based in Pittsburgh, Pennsylvania. The contract is for the provision of TARPEYO 4MG NDC 81749-0004-01, an emergency medication. The contract has an ultimate completion date of August 22, 2025 and was awarded on August 15, 2025. Pantherx Specialty, a subsidiary of Centene Corporation, is a specialized pharmacy that focuses on...
- This is a federal contract awarded by the Veterans Integrated Service Network 2 (VISN 2), a civilian agency, to Pantherx Specialty, LLC, a for-profit limited liability company based in Pittsburgh, Pennsylvania. The contract is for the purchase of TARPEYO 4MG for the New York Harbor, with an ultimate completion date of November 5, 2025 and a ceiling value of $10,896.98. The contract is a firm fixed-price purchase order and does not have a set-aside designation. Pantherx Specialty, LLC is the...
- The Department of Veterans Affairs, Veterans Integrated Service Network 2, awarded a firm fixed-price purchase order to Pantherx Specialty, LLC (doing business as Pantherx Specialty Pharmacy) on October 16, 2025, for TARPEYO 4mg (budesonide), a specialized pharmaceutical product. The contract carries a ceiling value of $10,896.98 and is scheduled for completion by November 17, 2025. This award was not issued under any set-aside designation. Pantherx Specialty, a Pittsburgh-based specialty...
This federal contract award, with a ceiling value of $85,242.15, was issued by the Department of Veterans Affairs Veterans Integrated Service Network 16 to Pantherx Specialty, LLC, a specialty pharmacy subsidiary of Centene Corporation. The contract is a firm fixed price purchase order for the supply of the drug Ruzurgi (amifampridine 10mg) to VA facilities within VISN 16. This contract supports the medical needs of veterans obtaining care through the VA health system. No set-aside designation was used, and no subcontractors were mentioned in the award information provided.
Generated 4/2/25, 11:04 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $85.2k | 12/19/19 |